Enveric Biosciences, Inc.(ENVB)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $48.6M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ENVB Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Enveric Biosciences, Inc. (ENVB), a Healthcare sector company. ENVB is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $48.6m in revenue and is scored on the micro-cap board instead. Top institutional holders of ENVB by reported 13-F value include Sio Capital Management, Ikarian Capital, AdvisorShares Investments, based on the most recent SEC filings. ENVB trades on the Nasdaq exchange and files with the SEC under CIK 890821. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ENVB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Enveric Biosciences, Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-3.0M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
+8.4% YoYOperating Income
+8.9% YoYEPS (Diluted)
+84.1% YoYTotal Assets
+65.3% YoYOp. Cash Flow
-5.4% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-8.8M +8.4% | $-9.6M +44.6% | $-17.3M +6.4% | $-18.5M +62.3% | $-49.0M -613.5% | $-6.9M |
| Operating Income | $-8.8M +8.9% | $-9.6M +41.4% | $-16.4M +40.0% | $-27.4M +57.6% | $-64.6M -1050.4% | $-5.6M |
| EPS (Diluted) | $-36.24 +84.1% | $-228.48 -88.4% | $-121.29 -833.0% | $-13.00 | — | — |
| Total Assets | $5.1M +65.3% | $3.1M -28.3% | $4.3M -78.0% | $19.6M -26.8% | $26.7M +552.2% | $4.1M |
| Operating Cash Flow | $-8.1M -5.4% | $-7.7M +45.2% | $-14.1M +17.8% | $-17.1M -49.7% | $-11.5M -194.6% | $-3.9M |
| Free Cash Flow | — | — | $-14.1M +20.5% | $-17.7M -52.2% | $-11.6M | — |
Get alerted when ENVB's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Enveric Biosciences, Inc. including:
Top Institutional Holders of ENVB
Sio Capital Management, LLC
$248.4K180,000 shIkarian Capital, LLC
$138.0K100,002 shAdvisorShares Investments LLC
$48.9K35,417 shRENAISSANCE TECHNOLOGIES LLC
$44.2K32,058 shARMISTICE CAPITAL, LLC
$44.2K32,000 shBOOTHBAY FUND MANAGEMENT, LLC
$41.6K30,142 shXTX Topco Ltd
$26.2K18,990 shStoneX Group Inc.
$21.9K11,814 shHRT FINANCIAL LP
$21.0K15,458 shVANGUARD CAPITAL MANAGEMENT LLC
$20.6K14,912 sh
| Fund | Value | Shares |
|---|---|---|
| Sio Capital Management, LLC | $248.4K | 180,000 |
| Ikarian Capital, LLC | $138.0K | 100,002 |
| AdvisorShares Investments LLC | $48.9K | 35,417 |
| RENAISSANCE TECHNOLOGIES LLC | $44.2K | 32,058 |
| ARMISTICE CAPITAL, LLC | $44.2K | 32,000 |
| BOOTHBAY FUND MANAGEMENT, LLC | $41.6K | 30,142 |
| XTX Topco Ltd | $26.2K | 18,990 |
| StoneX Group Inc. | $21.9K | 11,814 |
| HRT FINANCIAL LP | $21.0K | 15,458 |
| VANGUARD CAPITAL MANAGEMENT LLC | $20.6K | 14,912 |
More Healthcare Companies
View all Healthcare →Put ENVB on your watchlist
Track score changes the day Enveric Biosciences, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ENVB a good stock to buy?
13F Pro's AI-powered analysis of Enveric Biosciences, Inc. (ENVB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ENVB are available on the ENVB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ENVB is classified as a small company.
Which hedge funds own ENVB?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ENVB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Enveric Biosciences, Inc.'s investment landscape.